My vision for the School, and St Thomas’ Hospital more broadly, is for it to become the world leader in the clinical translation of healthcare engineering innovations. The School will focus on some of the biggest medical challenges where engineering can make a major contribution. We will harness the School’s world-class biomedical engineering and imaging expertise alongside the Guy's and St Thomas' NHS Foundation Trust’s world-renowned medical specialists and infrastructure; partner with global medical device companies; incorporate incubator space for start-ups; and tap London’s entrepreneurial energy and financial power, to enable revolutionary healthcare engineering that will change the lives of millions of patients. This setup will also provide a unique platform to train the next generation of healthcare engineers and physicians comfortable with the latest engineering technology.Professor Seb Ourselin
16 April 2018
First day for our new head of School Professor Sebastien Ourselin
Last Monday saw the first day in post for our new head of School, Professor Sebastien Ourselin.
Seb joins us from UCL where he was the Director of UCL’s Institute of Healthcare Engineering, the Wellcome/EPSRC Centre for Interventional and Surgical Sciences, Vice-Dean (Health) at the Faculty of Engineering Sciences and amongst other roles, he was the Director of the EPSRC Centre for Doctoral Training in medical imaging at UCL.
Seb's range of expertise and leadership experience will provide exciting opportunities for the School and the Faculty. As leader of the Translational Imaging Group, his research spans engineering solutions in imaging and medical devices. He has been instrumental in the development of and contribution to a number of postgraduate taught programmes. Through the UCL/UCLH NIHR Bio-medical Research Centre, he has led a broad range of translational activities, including minimally invasive fetal therapy, neuroimaging clinical trials and neurosurgery. Seb has published over 400 journal and conference articles and raised over £40M in research awards.